• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Biological response modifier--immunotherapeutic approaches in pancreatic cancer.

作者信息

Schmiegel W

机构信息

Medizinische Kern- und Poliklinik, Universitätskrankenhaus Eppendorf, Hamburg, FRG.

出版信息

Hepatogastroenterology. 1989 Dec;36(6):456-8.

PMID:2693301
Abstract

Three principles of immunological approaches to cancer therapy are currently under investigation. First the administration of monoclonal antibodies, given either alone or with peripheral mononuclear cells and/or human gamma interferon. Another area of interest is adoptive immunotherapy by means of in vitro lymphokine-activated and propagated killer cells. Finally, human recombinant cytokines (interferons, tumor necrosis factors) have attracted clinical interest. The clinical data thus far available for pancreatic cancer will be briefly reviewed.

摘要

相似文献

1
Biological response modifier--immunotherapeutic approaches in pancreatic cancer.
Hepatogastroenterology. 1989 Dec;36(6):456-8.
2
Immunological approach in the diagnosis, therapy and prognosis of the exocrine pancreatic cancer.免疫方法在外分泌性胰腺癌的诊断、治疗及预后中的应用
Roum Arch Microbiol Immunol. 2001 Jan-Mar;60(1):5-16.
3
[Therapy by biological response modifiers].[生物反应调节剂疗法]
Rinsho Ketsueki. 1989 Aug;30(8):1230-2.
4
[Antibody and immunotherapy in oncology. Which patients benefit?].[肿瘤学中的抗体与免疫疗法。哪些患者能从中获益?]
MMW Fortschr Med. 2001 Jun 21;143(25):24-8.
5
Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.结核分枝杆菌的免疫显性PstS1抗原是治疗膀胱癌的一种有效的生物反应调节剂。
BMC Cancer. 2004 Nov 26;4:86. doi: 10.1186/1471-2407-4-86.
6
The ideal biological response modifier.理想的生物反应调节剂。
Mol Biother. 1989;1(6):311-7.
7
[Immunotherapy for unresectable pancreatic cancer].[不可切除胰腺癌的免疫治疗]
Gan To Kagaku Ryoho. 2002 Mar;29(3):390-7.
8
[Current possibilities in immunotherapy of cancer].[癌症免疫疗法的当前可能性]
Schweiz Med Wochenschr. 1987 Feb 14;117(7):243-8.
9
[The anti-pancreatic cancer efficacy of LAK cells mediated by YPC3 monoclonal antibody in vitro and in vivo].YPC3单克隆抗体介导的LAK细胞在体外和体内的抗胰腺癌疗效
Zhonghua Zhong Liu Za Zhi. 1994 Sep;16(5):353-5.
10
Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.胰腺癌的过继性免疫治疗:由表达MUC1的人胰腺癌细胞系YPK-1刺激的细胞毒性T淋巴细胞
Oncol Rep. 2008 Jul;20(1):155-63.